![Uromune® i: valoración de los beneficios de la inmunoprofilaxis en infecciones del tracto urinario recurrentes desde farmacia comunitaria | Farmacéuticos Comunitarios Uromune® i: valoración de los beneficios de la inmunoprofilaxis en infecciones del tracto urinario recurrentes desde farmacia comunitaria | Farmacéuticos Comunitarios](https://www.farmaceuticoscomunitarios.org/sites/default/files/congreso_2020/png/99.png)
Uromune® i: valoración de los beneficios de la inmunoprofilaxis en infecciones del tracto urinario recurrentes desde farmacia comunitaria | Farmacéuticos Comunitarios
![Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects | BMC Infectious Diseases | Full Text Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects | BMC Infectious Diseases | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12879-019-4541-y/MediaObjects/12879_2019_4541_Fig3_HTML.png)
Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects | BMC Infectious Diseases | Full Text
![Urinary Tract Infection (UTI) Vaccine - AARE UROCARE - Female Urology | Urinary Incontinence Singapore Urinary Tract Infection (UTI) Vaccine - AARE UROCARE - Female Urology | Urinary Incontinence Singapore](https://aareurology.sg/wp-content/uploads/2023/06/utivaccine4-1024x683.jpg)
Urinary Tract Infection (UTI) Vaccine - AARE UROCARE - Female Urology | Urinary Incontinence Singapore
![PDF) Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects PDF) Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects](https://i1.rgstatic.net/publication/336866750_Active_immunoprophyilaxis_with_uromuneR_decreases_the_recurrence_of_urinary_tract_infections_at_three_and_six_months_after_treatment_without_relevant_secondary_effects/links/5fc2529b92851c933f6b830f/largepreview.png)